Search clinical trials for: transfusional hemosiderosis

Total 186 results

Haukeland University Hospital
Novartis

Withdrawn

Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome (DefeHEMY)

Myelodysplastic Syndromes | Hemochromatosis

Norway
Novartis Pharmaceuticals

Completed

Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food

Transfusional Hemosiderosis

United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis

Transfusional Hemosiderosis | Chronic Anemia

Japan, Turkey, Spain, Poland, Singapore
Shire

Withdrawn

Treatment of Iron Overload Requiring Chelation Therapy

Metabolic Diseases | Iron Metabolism Disorders | Iron Overload | Beta-thalassemia | Transfusional Hemosiderosis | Transfusional Iron Overload | Iron Chelation
Novartis Pharmaceuticals

Completed

Safety Study of Crushed Deferasirox Film Coated Tablets in Pediatric Patients With Transfusional Hemosiderosis (MIMAS)

Iron Overload

United Kingdom, Italy, Oman, United Arab Emirates, Lebanon, Thailand, Egypt
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload

Myelodysplastic Syndromes | Transfusion Dependent Iron Overload

Germany
Novartis

Completed

A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis

Beta-Thalassemia | Hemosiderosis

Egypt, Lebanon, Oman, Saudi Arabia, Syrian Arab Republic
Novartis Pharmaceuticals

Completed

A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity

Transfusional Iron Overload

United States, Greece, Italy
Children's Hospital Los Angeles
Novartis Pharmaceuticals

Terminated

Clinical Importance of Treating Iron Overload in Sickle Cell Disease

Anemia, Sickle Cell | Transfusion Hemosiderosis

United States
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Safety, Tolerability, and Efficacy of Deferasirox in MDS

Myelodysplastic Syndromes | Hemosiderosis

Italy
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload

Iron Overload

Germany
Novartis Pharmaceuticals

Completed

Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox

Transfusional Hemosiderosis

Egypt, Spain, United Kingdom, Jordan
Novartis Pharmaceuticals

Completed

Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload (CORDELIA)

Transfusional Hemosiderosis | Transfusional Iron Overload

Taiwan, Turkey, Egypt, United Kingdom, Thailand, Canada, China, Italy, Cyprus, Lebanon, United Arab Emirates
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis

Hematologic Diseases | Iron Overload | Hemoglobinopathies | Thalassemia | Beta-Thalassemia | Hemochromatosis | Anemia (Iron-Loading)
Ain Shams University

Unknown

Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload

Sickle Cell Disease | Beta-thalassemia Major | Iron Hemosiderosis

Egypt
Novartis Pharmaceuticals

Completed

Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration) (ESCALATOR)

Iron Overload | Hemosiderosis | Beta-thalassemia Major | Rare Anemia

Egypt, Oman, Saudi Arabia, Syrian Arab Republic, Lebanon
Novartis Pharmaceuticals

Completed

Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO).

Sickle Cell Disease

United States, Italy, United Kingdom, France, Canada
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis

Iron Overload | Hereditary Hemochromatosis

United States, Germany, Italy, Australia, Canada, France
Novartis Pharmaceuticals

Completed

Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients

Anemia | Hemosiderosis

United States, Germany, Belgium, United Kingdom, Italy, Canada, France
Erasme University Hospital

Recruiting

Transfusion Surveillance in Anaesthesia (STAR)

Blood Loss | Anesthesia | Transfusion Reaction | Blood Coagulation Disorder | Transfusion Related Complication | Side Effect | Anesthesia; Shock | Fresh Blood Stool

Belgium
Damascus University

Recruiting

Re-infusion of Unwashed Shed Blood During Off-pump Surgery

Coronary Artery Disease | Cardiovascular Complication | Blood Transfusion Complication

Syrian Arab Republic
Centre Hospitalier Sud Francilien

Not yet recruiting

Infectious and Non-infectious Lower Respiratory Diseases in Children With Down Syndrome Followed in Pediatric Pulmonology Consultations in Ile-de-France (ARBT21)

Down Syndrome

France
Guangdong Provincial People's Hospital

Not yet recruiting

The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis

Lung Cancer | Surgery | Autologous Blood Transfusion | Spinal Metastases | Blood Transfusion Complication
Azienda Ospedaliero-Universitaria di Modena

Recruiting

"Iron Overload and Endocrinological Diseases"

Iron Overload | Hemochromatosis | Thalassemia Major | Thalassemia Intermedia | Endocrinopathy

Italy
Children's Hospital of Chongqing Medical University

Recruiting

Hepatitis B Vaccination After Neonatal Surgery

Hepatitis B Virus Infection | Hepatitis B Vaccine Adverse Reaction | Blood Transfusion Complication | Vaccination Reaction | Digestive System Disorders of Fetus and Newborn

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children (Lef for IPH)

Idiopathic Pulmonary Hemosiderosis | Leflunomide

China
Qianfoshan Hospital

Recruiting

Analysis of the Effect of Iron Supplements on Iron Deficiency Anemia in Pregnancy

Iron Deficiency Anemia of Pregnancy | Iron Storage Disease

China
Ministry Of Health / Nineveh Health Directorate

Not yet recruiting

Role of Nefopam in Rituximab Transfusion Reaction

Nefopam
Ramsay Générale de Santé
European Clinical Trial Experts Network

Not yet recruiting

Iron Deposits in the Pancreas by MRI Method of Dialysis Patients With Hemosiderosis Iatrogenic (ERDFP) (ERDFP)

Dialysis | Iron Deposition | Iatrogenic Hemosiderosis

France
Karadeniz Technical University

Recruiting

Blood Transfusion in Patients With Lung Cancer

Transfusion-Transmitted Infection

Turkey
Bristol-Myers Squibb

Recruiting

A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.

Beta-thalassemia

China
University of Leipzig
Celgene Corporation

Recruiting

Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions (LENNON)

Myelodysplastic Syndromes | Anemia

Germany
Ospedale Sandro Pertini, Roma
Associazione Chirurghi Ospedalieri Italiani

Recruiting

Enhanced Recovery and Patient Blood Management in Colorectal Surgery (iCral4)

Colorectal Neoplasms | Anastomotic Leak | Colorectal Disorders | Blood Transfusion Complication

Italy
University of South Carolina
Prisma Health-Midlands; The Gerber Foundation

Recruiting

Blood Warming in Preterm Infants to Decrease Hypothermia

Preterm Birth | Hypothermia | Blood Transfusion Complication

United States
AC Camargo Cancer Center

Not yet recruiting

Transfusional Trigger in Post-operative Oncologic Patients in Critical Care

Surgery | Critical Care | Oncology | Transfusion

Brazil
Mahidol University

Recruiting

Perioperative Outcomes of Postpartum Hemorrhage in Patients Undergoing Cesarean Delivery

Cesarean Section Complications | Postpartum Hemorrhage | Anesthesia Complication | Blood Transfusion Complication | Uterine Atony With Hemorrhage

Thailand
Rennes University Hospital

Recruiting

Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis (Quali-SAT)

Haemochromatosis

France
Institute of Hematology & Blood Diseases Hospital...

Recruiting

Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.

Allergic Transfusion Reaction

China
Emory University
National Heart, Lung, and Blood Institute (NHLBI); Cerus Corporation

Recruiting

Red Blood Cell Survival in Sickle Cell Disease

Sickle Cell Disease

United States
Walton Centre NHS Foundation Trust
Instituto Grifols, S.A.

Recruiting

Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing (digG)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy | Multifocal Motor Neuropathy (MMN)

United Kingdom
Francis Corazza

Recruiting

Evaluation of the Clinical Performances of a Point of Care Analyzer Enabling Pre-transfusion ABOD Group Ultimate Verification at the Patient Bedside

Blood Transfusion Complication

Belgium
Perspectum

Recruiting

Repeatability and Reproducibility of Multiparametric MRI

Liver Diseases | Cirrhosis | Primary Sclerosing Cholangitis | Autoimmune Hepatitis | Hemochromatosis | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Primary Biliary Cirrhosis | Viral Hepatitis

Netherlands, United Kingdom
Cerus Corporation

Recruiting

INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections (RedeS)

Anemia

United States, Puerto Rico
University of Illinois at Chicago

Recruiting

Ph I/II Study of Allogeneic SCT for Clinically Aggressive Sickle Cell Disease (SCD)

Sickle Cell Disease

United States
National Institutes of Health Clinical Center (CC)

Active, not recruiting

Treatment of Hemochromatosis

Hemochromatosis

United States
University of Wisconsin, Madison
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...

Completed

MRI QSM Imaging for Iron Overload

Iron Overload | Hemochromatosis

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Cardiac Function in Patients With Hereditary Hemochromatosis

Hereditary Hemochromatosis

United States
University of Wisconsin, Madison
Johns Hopkins University; National Institute of Diabetes and Digestive and... and other collaborators

Enrolling by invitation

Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content

Iron Overload | Hemosiderosis | Hemochromatosis

United States
University of Southern California
University of Miami; University of Chicago; Medical College of Wisconsin; University... and other collaborators

Completed

UltraMTP in Adult Trauma Patients Undergoing Surgery Within 24 Hours: Effects on Mortality and Clinical Outcomes

Death | Trauma | Blood Transfusion Complication

United States
National Institutes of Health Clinical Center (CC)

Completed

Study of Transfusion-Transmitted Infections

Viral Disease | Blood Donation | Transfusion-Transmitted Infections

United States

Search clinical trials for: transfusional hemosiderosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations